Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elwyn Griffiths

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Biologicals : Journal of the International Association of Biological Standardization|August 20, 2014
Adventitious agents in viral vaccines: lessons learned from 4 case studiesJohn Petricciani, Rebecca Sheets, Elwyn Griffiths, et al.
Biologicals : Journal of the International Association of Biological Standardization|August 21, 2012
The WHO network of collaborating centres on standardization and regulatory evaluation of vaccinesIvana Knezevic, Elwyn Griffiths, John Petricciani, et al.
Biologicals : Journal of the International Association of Biological Standardization|September 20, 2011
Evaluation of similar biotherapeutic products: scientific and regulatory challengesElwyn Griffiths, Robin Thorpe, Meenu Wadhwa, et al.
Biologicals : Journal of the International Association of Biological Standardization|January 26, 2008
WHO informal consultation on regulatory evaluation of therapeutic biological medicinal products held at WHO Headquarters, Geneva, 19-20 April 2007Jeewon Joung, James S Robertson, Elwyn Griffiths, et al.
Biologicals : Journal of the International Association of Biological Standardization|September 13, 2011
WHO/KFDA joint workshop on implementing WHO guidelines on evaluating similar biotherapeutic products, Seoul, Republic of Korea 24-26 August, 2010Meenu Wadhwa, Hye-Na Kang, Ivana Knezevic, et al.
Annals of the New York Academy of Sciences|September 10, 2024
The importance of World Health Organization international reference standards in the product life cycle of biosimilarsHye-Na Kang, Meenu Wadhwa, Ivana Knezevic, et al.
Biologicals : Journal of the International Association of Biological Standardization|October 20, 2012
WHO/Health Canada meeting on regulatory considerations for evaluation and licensing of new meningococcal Group B vaccines, Ottawa, Canada, 3-4 October 2011Ian Feavers, Elwyn Griffiths, Maria Baca-Estrada, et al.
Revista Panamericana De Salud Publica = Pan American Journal of Public Health|May 26, 2021
Landscape of research, production, and regulation in venoms and antivenoms: a bibliometric analysisJosé Luis Di Fabio, María de Los Ángeles Cortés Castillo, Elwyn Griffiths
Clinical Chemistry and Laboratory Medicine|July 20, 2022
Complexity of serological assays and misunderstandings of WHO International UnitsIvana Knezevic, Giada Mattiuzzo, Mark Page, et al.
Influenza and Other Respiratory Viruses|June 15, 2011
Confronting the next pandemic--workshop on lessons learned from potency testing of pandemic (H1N1) 2009 influenza vaccines and considerations for future potency tests, Ottawa, Canada, July 27-29, 2010Stephanie Hardy, Maryna Eichelberger, Elwyn Griffiths, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Biologicals : Journal of the International Association of Biological Standardization|August 20, 2014
Adventitious agents in viral vaccines: lessons learned from 4 case studiesJohn Petricciani, Rebecca Sheets, Elwyn Griffiths, et al.
Biologicals : Journal of the International Association of Biological Standardization|August 21, 2012
The WHO network of collaborating centres on standardization and regulatory evaluation of vaccinesIvana Knezevic, Elwyn Griffiths, John Petricciani, et al.
Biologicals : Journal of the International Association of Biological Standardization|September 20, 2011
Evaluation of similar biotherapeutic products: scientific and regulatory challengesElwyn Griffiths, Robin Thorpe, Meenu Wadhwa, et al.
Biologicals : Journal of the International Association of Biological Standardization|January 26, 2008
WHO informal consultation on regulatory evaluation of therapeutic biological medicinal products held at WHO Headquarters, Geneva, 19-20 April 2007Jeewon Joung, James S Robertson, Elwyn Griffiths, et al.
Biologicals : Journal of the International Association of Biological Standardization|September 13, 2011
WHO/KFDA joint workshop on implementing WHO guidelines on evaluating similar biotherapeutic products, Seoul, Republic of Korea 24-26 August, 2010Meenu Wadhwa, Hye-Na Kang, Ivana Knezevic, et al.
Annals of the New York Academy of Sciences|September 10, 2024
The importance of World Health Organization international reference standards in the product life cycle of biosimilarsHye-Na Kang, Meenu Wadhwa, Ivana Knezevic, et al.
Biologicals : Journal of the International Association of Biological Standardization|October 20, 2012
WHO/Health Canada meeting on regulatory considerations for evaluation and licensing of new meningococcal Group B vaccines, Ottawa, Canada, 3-4 October 2011Ian Feavers, Elwyn Griffiths, Maria Baca-Estrada, et al.
Revista Panamericana De Salud Publica = Pan American Journal of Public Health|May 26, 2021
Landscape of research, production, and regulation in venoms and antivenoms: a bibliometric analysisJosé Luis Di Fabio, María de Los Ángeles Cortés Castillo, Elwyn Griffiths
Clinical Chemistry and Laboratory Medicine|July 20, 2022
Complexity of serological assays and misunderstandings of WHO International UnitsIvana Knezevic, Giada Mattiuzzo, Mark Page, et al.
Influenza and Other Respiratory Viruses|June 15, 2011
Confronting the next pandemic--workshop on lessons learned from potency testing of pandemic (H1N1) 2009 influenza vaccines and considerations for future potency tests, Ottawa, Canada, July 27-29, 2010Stephanie Hardy, Maryna Eichelberger, Elwyn Griffiths, et al.
Pageof 3